close

Join our Mailing List

Receive the latest news, event invites, funding opportunities and more from the Ontario Institute for Cancer Research.

Tag
Radiopharmaceuticals And Chemical Probes
Sep 14, 2022
<strong>New CPDC spinout company aims to become global leader in developing and distributing radiopharmaceuticals</strong>
New CPDC spinout company aims to become global leader in developing and distributing radiopharmaceuticals
Jun 16, 2020
OICR joins European consortium to ‘enable and unlock biology in the open’
OICR joins European consortium to ‘enable and unlock biology in the open’
Aug 02, 2018
Ontario centre attracts national attention for probe research, development and commercialization
Ontario centre attracts national attention for probe research, development and commercialization
Oct 04, 2017
FACIT Portfolio Company Fusion Pharmaceuticals Closes US$46M Oversubscribed Series A
FACIT Portfolio Company Fusion Pharmaceuticals Closes US$46M Oversubscribed Series A
Feb 10, 2017
How chemical probes can boost cancer research
How chemical probes can boost cancer research
Mar 16, 2016
FACIT invests in new CPDC spin-out company to aid development of potent radiotherapeutic
FACIT invests in new CPDC spin-out company to aid development of potent radiotherapeutic
Dec 16, 2015
FACIT Announces Investment in Fusion Pharmaceuticals and Alpha-Emitting Radiotherapeutics
FACIT Announces Investment in Fusion Pharmaceuticals and Alpha-Emitting Radiotherapeutics
Looking Ahead
Receive the latest news, event invites, funding opportunities and more from the Ontario Institute for Cancer Research.
Subscribe